IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9801913 B1

PDFFull Text
Date of Patent:
Oct. 31, 2017

Filed:

Sep. 28, 2005

Barrier layer

Applicants:

Joseph Ferraro, Londonderry, NH (US);

Lisa Rogers, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Theodore Karwoski, Hollis, NH (US);

Steve A. Herweck, Nashua, NH (US);

Keith Faucher, Nashua, NH (US);

Philip Mcnamara, Concord, NH (US);

Inventors:

Joseph Ferraro, Londonderry, NH (US);

Lisa Rogers, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Theodore Karwoski, Hollis, NH (US);

Steve A. Herweck, Nashua, NH (US);

Keith Faucher, Nashua, NH (US);

Philip McNamara, Concord, NH (US);

Assignee:

ATRIUM MEDICAL CORPORATION, Hudson, NH (US);

Attorney:

Wesley Scott Ashton

Primary Examiner:

Robert A Wax

Assistant Examiner:

Caralynne Helm

Int. Cl.
CPC ...
A61K 35/60 (2006.01); A61K 38/13 (2006.01); A61L 27/36 (2006.01); A61L 27/52 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/225 (2006.01); A61K 31/355 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61L 31/10 (2006.01); A61L 27/54 (2006.01); A61F 13/02 (2006.01); A61L 2/07 (2006.01); A61L 2/08 (2006.01); A61L 2/20 (2006.01); A61L 31/00 (2006.01); A61L 31/14 (2006.01); A61F 2/06 (2013.01); B05D 3/06 (2006.01);
U.S. Cl.
CPC ...
A61K 35/60 (2013.01); A61F 13/02 (2013.01); A61F 13/023 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 31/225 (2013.01); A61K 31/355 (2013.01); A61K 38/13 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61L 2/07 (2013.01); A61L 2/081 (2013.01); A61L 2/087 (2013.01); A61L 2/206 (2013.01); A61L 2/208 (2013.01); A61L 27/36 (2013.01); A61L 27/3604 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 31/005 (2013.01); A61L 31/10 (2013.01); A61L 31/145 (2013.01); A61F 2/06 (2013.01); A61F 2250/0067 (2013.01); A61L 2202/24 (2013.01); A61L 2300/22 (2013.01); A61L 2300/252 (2013.01); A61L 2300/404 (2013.01); A61L 2300/41 (2013.01); A61L 2300/414 (2013.01); A61L 2300/42 (2013.01); A61L 2300/602 (2013.01); B05D 3/067 (2013.01);
Abstract

A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.

Find Patent Forward Citations

Loading…